Achieve Life Sciences Inc. (ACHV) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Achieve Life Sciences Inc... (ACHV)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.25

0.10 (3.17%)

At close: Jan 15, 2025, 1:40 PM

undefined% (undefined)

Bid	3.24
Market Cap	111.77M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.12
PE Ratio (ttm)	-2.9
Forward PE	n/a
Analyst	Buy

Ask	3.27
Volume	74,138
Avg. Volume (20D)	160,703
Open	3.18
Previous Close	3.15
Day's Range	3.16 - 3.34
52-Week Range	3.12 - 5.59
Beta	undefined

About ACHV

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol....

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Oct 12, 1995

Employees 22

Stock Exchange NASDAQ

Ticker Symbol ACHV

Website https://www.achievelifesciences.com

Analyst Forecast

According to 5 analyst ratings, the average rating for ACHV stock is "Buy." The 12-month stock price forecast is $12, which is an increase of 269.23% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

News

2 months ago · seekingalpha.com

Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Nicole Jones - IR Richard Stewart - Chief Executive Officer Cindy Jacobs - ...